A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas. // ESMO Open. – URL: https://www.sciencedirect.com/science/article/pii/S2059702926025299?dgcid=rss_sd_all
A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas. ESMO Open. https://www.sciencedirect.com/science/article/pii/S2059702926025299?dgcid=rss_sd_all
“A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas.” ESMO Open.
@article{article98930,
title = {A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas},
journal = {ESMO Open},
url = {https://www.sciencedirect.com/science/article/pii/S2059702926025299?dgcid=rss_sd_all}
}